These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 22302998

  • 1. E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells.
    Kim WD, Kim YW, Cho IJ, Lee CH, Kim SG.
    J Cell Sci; 2012 Mar 01; 125(Pt 5):1284-95. PubMed ID: 22302998
    [Abstract] [Full Text] [Related]

  • 2. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL, McCauley L, Trevino I, Wigley WC, Ferguson DA.
    PLoS One; 2015 Mar 01; 10(8):e0135257. PubMed ID: 26301506
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory role of the KEAP1-NRF2 pathway in TGFβ1-stimulated renal epithelial transition to fibroblastic cells: a modulatory effect on SMAD signaling.
    Ryoo IG, Ha H, Kwak MK.
    PLoS One; 2014 Mar 01; 9(4):e93265. PubMed ID: 24691097
    [Abstract] [Full Text] [Related]

  • 4. Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.
    Zhan L, Zhang H, Zhang Q, Woods CG, Chen Y, Xue P, Dong J, Tokar EJ, Xu Y, Hou Y, Fu J, Yarborough K, Wang A, Qu W, Waalkes MP, Andersen ME, Pi J.
    Free Radic Biol Med; 2012 Aug 15; 53(4):758-68. PubMed ID: 22684020
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T, Ishii Y, Homma S, Morishima Y, Kurishima K, Itoh K, Yamamoto M, Minami Y, Noguchi M, Hizawa N.
    Oncogene; 2012 Nov 08; 31(45):4768-77. PubMed ID: 22249257
    [Abstract] [Full Text] [Related]

  • 6. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway.
    Yu M, Li H, Liu Q, Liu F, Tang L, Li C, Yuan Y, Zhan Y, Xu W, Li W, Chen H, Ge C, Wang J, Yang X.
    Cell Signal; 2011 May 08; 23(5):883-92. PubMed ID: 21262351
    [Abstract] [Full Text] [Related]

  • 7. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology.
    Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y, Park YM.
    Cancer Res; 2007 Jan 15; 67(2):546-54. PubMed ID: 17234762
    [Abstract] [Full Text] [Related]

  • 8. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA.
    Kim JH, Choi YK, Lee KS, Cho DH, Baek YY, Lee DK, Ha KS, Choe J, Won MH, Jeoung D, Lee H, Kwon YG, Kim YM.
    Free Radic Biol Med; 2012 Aug 01; 53(3):629-40. PubMed ID: 22609006
    [Abstract] [Full Text] [Related]

  • 9. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM, Kansanen E, Pölönen P, Heinäniemi M, Levonen AL.
    Adv Cancer Res; 2014 Aug 01; 122():281-320. PubMed ID: 24974185
    [Abstract] [Full Text] [Related]

  • 10. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies.
    Hu L, Miao W, Loignon M, Kandouz M, Batist G.
    Cancer Chemother Pharmacol; 2010 Aug 01; 66(3):467-74. PubMed ID: 19940992
    [Abstract] [Full Text] [Related]

  • 11. Keap1 regulates the constitutive expression of GST A1 during differentiation of Caco-2 cells.
    Kusano Y, Horie S, Shibata T, Satsu H, Shimizu M, Hitomi E, Nishida M, Kurose H, Itoh K, Kobayashi A, Yamamoto M, Uchida K.
    Biochemistry; 2008 Jun 10; 47(23):6169-77. PubMed ID: 18476723
    [Abstract] [Full Text] [Related]

  • 12. Cdc42-Interacting Protein 4 Represses E-Cadherin Expression by Promoting β-Catenin Translocation to the Nucleus in Murine Renal Tubular Epithelial Cells.
    Xu C, Zhou Q, Liu L, Liu P, Pei G, Zeng R, Han M, Xu G.
    Int J Mol Sci; 2015 Aug 14; 16(8):19170-83. PubMed ID: 26287173
    [Abstract] [Full Text] [Related]

  • 13. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.
    Zhang P, Singh A, Yegnasubramanian S, Esopi D, Kombairaju P, Bodas M, Wu H, Bova SG, Biswal S.
    Mol Cancer Ther; 2010 Feb 14; 9(2):336-46. PubMed ID: 20124447
    [Abstract] [Full Text] [Related]

  • 14. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
    Zhang HS, Li HY, Zhou Y, Wu MR, Zhou HS.
    Free Radic Biol Med; 2009 Aug 01; 47(3):261-8. PubMed ID: 19409485
    [Abstract] [Full Text] [Related]

  • 15. iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding.
    Ge W, Zhao K, Wang X, Li H, Yu M, He M, Xue X, Zhu Y, Zhang C, Cheng Y, Jiang S, Hu Y.
    Cancer Cell; 2017 Nov 13; 32(5):561-573.e6. PubMed ID: 29033244
    [Abstract] [Full Text] [Related]

  • 16. Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.
    Korenori Y, Tanigawa S, Kumamoto T, Qin S, Daikoku Y, Miyamori K, Nagai M, Hou DX.
    Mol Nutr Food Res; 2013 May 13; 57(5):854-64. PubMed ID: 23390006
    [Abstract] [Full Text] [Related]

  • 17. Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha.
    Wu J, Wang H, Tang X.
    Biochem Biophys Res Commun; 2014 Sep 26; 452(3):554-9. PubMed ID: 25172665
    [Abstract] [Full Text] [Related]

  • 18. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3.
    Rojo AI, Medina-Campos ON, Rada P, Zúñiga-Toalá A, López-Gazcón A, Espada S, Pedraza-Chaverri J, Cuadrado A.
    Free Radic Biol Med; 2012 Jan 15; 52(2):473-87. PubMed ID: 22142471
    [Abstract] [Full Text] [Related]

  • 19. Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells.
    Yuan X, Xu C, Pan Z, Keum YS, Kim JH, Shen G, Yu S, Oo KT, Ma J, Kong AN.
    Mol Carcinog; 2006 Nov 15; 45(11):841-50. PubMed ID: 16739127
    [Abstract] [Full Text] [Related]

  • 20. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
    Shin CS, Her SJ, Kim JA, Kim DH, Kim SW, Kim SY, Kim HS, Park KH, Kim JG, Kitazawa R, Cheng SL, Civitelli R.
    J Bone Miner Res; 2005 Dec 15; 20(12):2200-12. PubMed ID: 16294273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.